Stanovisko ČSAT ke Konsenzu EAS 2021: Lipoproteiny bohaté na triglyceridy a jejich remnantní částice – přehled metabolizmu, role při aterosklerotickém kardiovaskulárním onemocnění a nové terapeutické strategie

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	Statement CSAT on Consensus EAS 2021: Triglyceride-rich lipoproteins and their remnants – metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies
Authors	VRABLÍK Michal BLAHA Vladimír CÍFKOVÁ Renata FREIBERGER Tomáš KARÁSEK David KRAML Pavel PIŤHA Jan ROSOLOVÁ Hana SOŠKA Vladimír ŠTULC Tomáš URBANOVÁ Zuzana MAŠKOVÁ Jana
Year of publication	2022
MU Faculty or unit	Faculty of Medicine
Web	https://www.atheroreview.eu/casopisy/athero-review/2022-3-25/stanovisko-csat-ke-konsenzu-eas-2021-lipoproteiny-bohate-na-triglyceridy-a-jejich-remnantni-castice-prehled-metabolizmu-role-pri-aterosklerotickem-kardiovaskularnim-onemocneni-a-nove-terapeutic
Attached files	Stanovisko_CSAT_ke_Konsenzu_EAS_2021_Lipoproteiny_bohate_na_triglyceridy_a_jejich_remnantni_castice_-_prehled_metabolizmu__role_pri_aterosklerotickem_kardiovaskularnim_onemocneni_a_nove_terapeuticke_strategie.pdf
Description	In September 2021, an expert consensus on triglyceride-rich lipoproteins and their remnant particles was published in the European Heart Journal. The Committee of the Czech Society for Atherosclerosis (CSAT) developed the following Opinion summarizing the most important information. However, this CSAT Opinion does not replace the full text of the EAS 2021 Consensus. Those interested in the detailed text are encouraged to read the original full text.
Related projects:	Národní institut pro léčbu metabolických a kardiovaskulárních onemocnění